GHK-Cu Monitoring Schedule: Labs & Exams You Need At a glance Drug / GHK-Cu is a tripeptide-copper(II) complex first isolated from human plasma albumin Route / subcutaneous injection or topical (compounded under FDA section 503A) Baseline labs / serum copper, ceruloplasmin, CBC with differential, CMP including liver enzymes Recheck interval / 4 weeks after initiation, then every 8 to 12 weeks Normal serum copper / 70 to 140 g/dL (11 to 22 mol/L) Ceruloplasmin target / 20 to 35 mg/dL Liver enzymes / ALT and AST should remain below 2x upper limit of normal 24-hour urine copper / ordered if serum copper exceeds 155 g/dL on two consecutive draws Skin exam / baseline and every 12 weeks for subcutaneous injection sites Discontinuation trigger / serum copper above 200 g/dL or ceruloplasmin below 15 mg/dL How GHK-Cu Works: Mechanism Before Monitoring GHK-Cu is glycyl-L-histidyl-L-lysine bound to a single copper(II) ion
Data were filtered using Trimmomatic(v0.39) in the CUT&Tag analysis pipeline
Moreover, skeletal muscle injury models have suggested a beneficial effect not only for disturbances that occur as a result of direct trauma but also for systemic insults including hyperkalemia and hypermagnesia
103,104,105 These toxic side effects are caused, at least in part, by the synergistic activity of glutaminase in ASNase
To receive my blog articles in your inbox, you can sign up for my e-newsletter here
Nature 412 , 346351 (2001)
